Compare GNT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GNT | INO |
|---|---|---|
| Founded | 2011 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.2M | 116.1M |
| IPO Year | N/A | 1998 |
| Metric | GNT | INO |
|---|---|---|
| Price | $8.42 | $1.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 40.9K | ★ 1.9M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 6.61% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | N/A | ★ $182,337.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23,060.18 |
| P/E Ratio | $5.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.59 | $1.30 |
| 52 Week High | $5.40 | $2.98 |
| Indicator | GNT | INO |
|---|---|---|
| Relative Strength Index (RSI) | 78.57 | 38.02 |
| Support Level | $7.72 | $1.47 |
| Resistance Level | $8.14 | $1.70 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 98.51 | 26.15 |
GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.